相关实验视频

Updated: May 5, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K

一个全面的目标小组允许扩大神经内分泌瘤的遗传谱

Uliana A Tsoy1, Polina S Sokolnikova1, Ekaterina N Kravchuk1

  • 1World-Class Research Centre for Personalized Medicine, Almazov National Medical Research Centre, Saint Petersburg, Russian Federation.

Neuroendocrinology
|November 13, 2024
PubMed
概括

向基因小组 (TGP) 在神经内分泌瘤 (NETs) 中发现了新的遗传变异,包括胰岛素瘤和染细胞瘤的新兴关联. 这项研究扩大了对NET的理解.

关键词:
基因检测是一种基因检测.这是一种胰岛素瘤.神经内分泌瘤的神经内分泌瘤副甲状腺腺瘤 副甲状腺腺瘤染细胞瘤 (Pheochromocytoma) 是一种细胞瘤.目标基因面板是目标基因面板.

更多相关视频

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.0K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.1K

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84